Regulators are actively encouraging medtech companies to use real-world data and synthetic control arms. Heres why this is ...
Oxford Mail on MSN
First patient treated in Oxford in second phase of gene therapy trial
The first patient has been treated in Oxford in the second phase of an international clinical trial testing a new gene ...
John Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is ...
Trachoma is the leading cause of infectious blindness in the world, with Ethiopia the most impacted country in Africa. In a ...
The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...
Understanding Testosterone Replacement Therapy and Its Alternatives Clearwater, United States – January 5, 2026 / The Confidence Clinic / Clearwater-based physicians emphasize evidence-based care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback